Multitarget Direct‐Acting Antiviral Therapy Is Associated With Superior Immunologic Recovery in Patients Coinfected With Human Immunodeficiency Virus and Hepatitis C Virus

Patients coinfected with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) have higher levels of immune activation, impaired antigen‐specific responses, and accelerated fibrogenesis compared to patients monoinfected with HCV. Whether different direct‐acting antiviral (DAA) combinations...

Descripción completa

Detalles Bibliográficos
Autores principales: Shrivastava, Shikha, Bhatta, Manasa, Ward, Haley, Romani, Sara, Lee, Rebecca, Rosenthal, Elana, Osinusi, Anu, Kohli, Anita, Masur, Henry, Kottilil, Shyam, Wilson, Eleanor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287478/
https://www.ncbi.nlm.nih.gov/pubmed/30556035
http://dx.doi.org/10.1002/hep4.1258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287478/
https://www.ncbi.nlm.nih.gov/pubmed/30556035
http://dx.doi.org/10.1002/hep4.1258

Ejemplares similares